Eisai Farmacêutica S.A.
1 clinical trials · Sponsor
◉ Watch Eisai Farmacêutica S.A.
| Record | Firm | Date |
|---|---|---|
| Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer (NCT02790320) | Eisai Farmacêutica S.A. | 2012-06-01 |
Track Eisai Farmacêutica S.A. automatically
Every clearance here is in the API, with alerts when new ones post.